Selenious acid
Identification
- Summary
Selenious acid is an ingredient found in supplements, vitamins, parenteral nutrition, and dandruff shampoo.
- Brand Names
- Multitrace-5, Multrys
- Generic Name
- Selenious acid
- DrugBank Accession Number
- DB11127
- Background
Selenious acid is the acid form of sodium selenite, a form of selenium 8.
Selenium is an essential trace element and antioxidant. It is a cofactor metabolic enzyme regulation. It also plays an important role in maintaining the general health of tissue and muscle and has antioxidant properties. Selenium is a component of glutathione peroxidase enzyme, which protects cell components from oxidative damage due to peroxides produced during cellular metabolism 13.
Selenium (Se) has been demonstrated to prevent cancer in numerous animal models when administered selenium at levels exceeding the nutritional requirements. One study showed efficacy in the prevention of malignancy while utilizing a selenium supplement in humans. The reports from such studies have heightened the interest in additional human selenium supplementation studies to validate the results in larger populations 15.
Interestingly, selenium is being studied as a potential therapy in the prevention or management of atherosclerosis 18.
- Type
- Small Molecule
- Groups
- Approved, Investigational
- Structure
- Weight
- Average: 128.97
Monoisotopic: 129.916915758 - Chemical Formula
- H2O3Se
- Synonyms
- selenige Säure
- Selenious acid
- Selenous acid
- External IDs
- UN 3283
- UN-3283
Pharmacology
- Indication
Selenium injection is indicated for use as a supplement to intravenous solutions given for total parenteral nutrition (TPN). Administration of selenious acid in TPN formulas helps to maintain plasma selenium levels and also to maintain endogenous stores to prevent deficiency 19.
Selenium compounds, such as selenium sulfide, are used topically in anti-dandruff shampoos and in cases of seborrhea 13.
For the purpose of brevity, selenite will the focus of discussion, and more information about selenium can be obtained at Selenium.
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
- Associated Therapies
- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Selenium is a component glutathione peroxidase, which protects cells from oxidative damage caused by peroxidases produced during cellular metabolism 8.
Selenium is needed to maintain the circulatory system. It also keeps the heart muscle and skin tissue healthy. It may also help in the prevention of cancer due to its stimulation of antioxidant activity and protection of cell membranes 13, 3.
Selenious acid preserves vitamin E, which improves the cell's antioxidant defense, and plays an important role in the structure of teeth 8.
Prolonged TPN (total parenteral nutrition) support in humans has resulted in selenium deficiency symptoms which include muscle pain and tenderness. The symptoms have been reported to respond to supplementation of TPN solutions with selenium Selenium, 19.
Pediatric conditions, Keshan disease, and Kwashiorkor have been associated with low dietary intake of selenium. The conditions are endemic to geographical areas marked by low selenium content in the soil. Dietary supplementation with selenium salts has been reported to reduce the incidence of the conditions among affected children 19.
- Mechanism of action
Sodium selenite likely has the same mechanism of action as Selenium.
The most important physiological role of sodium selenite is associated with its presence as an active component of many enzymes and proteins, in addition to its antioxidative role. Selenium has been shown to activate anticancer agents, prevent heart and vascular diseases, exhibit anti-proliferative and anti-inflammatory properties, and to stimulate the immune system 22.
Its anticancer properties may be explained by the oxidation of free sulfhydryl groups. Tumor cells express free sulfhydryl groups (–SH) on the surface of their cell membranes and contribute to uncontrolled cell division. Only those compounds that can oxidize these groups to disulfides (S–S) may inhibit this process. Some organic forms of selenium, including selenocysteine, methylseleninic acid, and Se-methylselenocysteine have been established to be antioxidants. However, their anticancer mechanism is still not well understood 22.
Selenious acid, during an in vitro study, was found to stimulate hemoglobin synthesis in three different malignant erythroleukemia cell lines (MEL) 8. It has also been shown to increase the release of interleukin 2 in a dose-dependent manner 6. Interleukin-2 is made by a type of T lymphocyte (white blood cell). It increases the growth and activity of other T-lymphocytes and B-lymphocytes and this contributes to the development of the immune system 6.
- Absorption
The absorption of selenite following oral administration approximately 40-70% of an oral dose, based on studies done in humans 20.
Selenoprotein P, the plasma form of selenium, contains at least 40% of the total selenium in plasma 25. Deletion of the gene for selenoprotein P in mouse models alters the distribution of selenium in body tissues suggesting that selenoprotein P is necessary for selenium transport 4.
- Volume of distribution
Following oral intake and absorption, selenium from sodium selenite is found in the highest concentrations in the liver and kidneys of humans and animals 20.
In one study, tissue samples taken at autopsy from 46 healthy individuals killed in accidents and from 75 corpses of victims of various diseases to analyze selenium levels and distribution 4. The per-weight-unit basis of selenium levels ng/gm in wet in tissues decreased in the following order: kidney (469) > liver > spleen > pancreas > heart > brain > lung > bone > skeletal muscle. The highest proportion of body selenium was found in skeletal muscles (27.5%) 4, 24. Significantly less selenium was measured in bones (16%) and blood (10%). In the tissues of cancer corpses, the selenium levels were lower than levels in the control group. The lowest selenium concentrations were measured in alcoholic livers 4.
- Protein binding
Not Available
- Metabolism
Absorbed selenium, from both inorganic sources such as selenite and organic sources including selenomethionine, is metabolized to hydrogen selenide, and subsequently incorporated into essential selenoproteins 20.
In vivo, selenium compounds are generally metabolized to reduced states. For example, quadrivalent selenium (Se+4) in selenite often undergoes reduction to Se−2, metabolized firstly to H2Se and, finally, being methylated to various excretory forms. Selenious acid to oxidize sulfurous acid: H2SeO3 + 2H2SO3 → Se0 + 2H2SO4 + H2O 10.
Se may also produce reactive oxygen species and, thereby, exert cancer-selective cytotoxicity. Selenodiglutathione (SDG) is a primary Se metabolite conjugated to two glutathione (GSH) moieties. Selenodiglutathione increases intracellular selenium accumulation and is significantly more toxic than selenous acid (H2SeO3). 2.
The liver is the central organ for selenium regulation and produces excretory selenium forms to regulate whole-body selenium 10.
Hover over products below to view reaction partners
- Route of elimination
Selenium is eliminated mainly in the urine. However, significant endogenous losses through the feces can also occur 23. The rate of excretion varies with the chemical form of selenium used in supplementation and the route of administration. Other minor routes of elimination are lungs and skin 19.
Analysis of 72-hour urine sampling from a study of 48 Norwegian women given a 200 μg supplement of selenium in the form of selenite indicated approximately 50% absorption of selenite 20.
- Half-life
30 days in beagle dogs 8.
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
The toxicity of selenium has been consistently well documented. However, some early studies reported that selenium may be a carcinogen. Nelson et al. (1943) showed that rats fed diets containing Se as seleniferous wheat developed hepatic tumors and low-grade carcinomas in 11 out 53 study animals 11.
Selenium at high doses (15-30 mcg/egg) has been reported to have significant adverse embryological effects on developing chickens. There currently no adequate and well-controlled studies in pregnant women. Selenious acid injections should be used during pregnancy only when the potential benefits justify the potential risk to the growing fetus 20.
The presence of selenium in the placenta and the umbilical cord blood has been reported in humans 20.
Overdosage symptoms with selenious acid include:
Acute Brick red–color gastric mucosa, cerebral edema, coma, death, fulminating peripheral vascular collapse, garlic or sour breath odor, gastrointestinal disturbance, hemolysis, hypersalivation, internal vascular congestion, liver necrosis, muscle spasms, pulmonary edema, and restlessness 20.
Chronic Dental defects, dermatitis, garlic odor of breath and/or sweat, gastrointestinal disorders, hair loss, mental depression, metallic taste, nervousness, nausea, vomiting, weak nails 20.
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareAbacavir Abacavir may decrease the excretion rate of Selenious acid which could result in a higher serum level. Aceclofenac Aceclofenac may decrease the excretion rate of Selenious acid which could result in a higher serum level. Acemetacin Acemetacin may decrease the excretion rate of Selenious acid which could result in a higher serum level. Acetaminophen Acetaminophen may decrease the excretion rate of Selenious acid which could result in a higher serum level. Acetazolamide Acetazolamide may increase the excretion rate of Selenious acid which could result in a lower serum level and potentially a reduction in efficacy. Acetylsalicylic acid Acetylsalicylic acid may decrease the excretion rate of Selenious acid which could result in a higher serum level. Aclidinium Aclidinium may decrease the excretion rate of Selenious acid which could result in a higher serum level. Acrivastine Acrivastine may decrease the excretion rate of Selenious acid which could result in a higher serum level. Acyclovir Acyclovir may decrease the excretion rate of Selenious acid which could result in a higher serum level. Adefovir dipivoxil Adefovir dipivoxil may decrease the excretion rate of Selenious acid which could result in a higher serum level. Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice.Learn more - Food Interactions
- No interactions found.
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Product Ingredients
Ingredient UNII CAS InChI Key Sodium selenite HIW548RQ3W 10102-18-8 BVTBRVFYZUCAKH-UHFFFAOYSA-L Sodium selenite pentahydrate 0WV4L961ZV 26970-82-1 TUANAMBRHOLYTH-UHFFFAOYSA-L - Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Micro Se Solution 40 mcg / mL Intravenous Sandoz Canada Incorporated 1993-12-31 Not applicable Canada Selenium Injection, solution 65.4 ug/1mL Intravenous AMERICAN REGENT, INC. 1990-09-30 2021-03-31 US Selepen Solution 40 mcg / mL Intravenous Partners Health Care, Inc. 1997-01-16 2008-02-15 Canada Selepen Inj 40mcg/ml USP Liquid 40 mcg / mL Intravenous Lyphomed, Division Of Fujisawa Canada Inc. 1984-12-31 1997-01-30 Canada - Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Formula-SE Tablet 30 mcg / tab Oral Gesar Ag 1997-09-26 2001-07-02 Canada Selenium Supplement Capsule 30 mcg / cap Oral For Mor International Inc. 2000-03-25 2004-08-11 Canada - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image ADDAMEL INFUSION N Sodium selenite pentahydrate (105 mcg) + Chromic chloride hexahydrate (53.3 mcg) + Cupric chloride dihydrate (3.4 mg) + Ferric chloride hexahydrate (5.4 mg) + Manganese chloride tetrahydrate (990 mcg) + Potassium Iodide (166 mcg) + Sodium fluoride (2.1 mg) + Sodium molybdate dihydrate (48.5 mcg) + Zinc chloride (13.6 mg) Solution, concentrate Intravenous FRESENIUS KABI COLOMBIA S.A.S. 2006-11-10 2009-05-08 Colombia ADDAMEL N FOR INFUSION Sodium selenite (6.9 mcg/ml) + Chromic chloride hexahydrate (5.33 mcg/ml) + Cupric chloride dihydrate (0.34 mg/ml) + Ferric chloride hexahydrate (0.54 mg/ml) + Manganese chloride tetrahydrate (99 mcg/ml) + Potassium Iodide (16.6 mcg/ml) + Sodium fluoride (0.21 mg/ml) + Sodium molybdate dihydrate (4.85 mcg/ml) + Zinc chloride (1.36 mg/ml) Injection Intravenous FRESENIUS KABI (SINGAPORE) PTE LTD 1992-01-31 Not applicable Singapore ADDAVEN CONCENTRATE FOR SOLUTION FOR INFUSION Sodium selenite (17.29 mcg/ml) + Chromic chloride hexahydrate (5.33 mcg/ml) + Cupric chloride dihydrate (102.3 mcg/ml) + Ferric chloride hexahydrate (540 mcg/ml) + Manganese chloride tetrahydrate (19.79 mcg/ml) + Potassium Iodide (16.6 mcg/ml) + Sodium fluoride (210 mcg/ml) + Sodium molybdate dihydrate (4.85 mcg/ml) + Zinc chloride (1050 mcg/ml) Solution Intravenous FRESENIUS KABI (SINGAPORE) PTE LTD 2017-07-24 Not applicable Singapore Addaven Konzentrat zur Herstellung einer Infusionslösung Sodium selenite (17.3 μg/ml) + Chromic chloride hexahydrate (5.33 μg/ml) + Cupric chloride dihydrate (0.1 mg/ml) + Ferric chloride hexahydrate (0.54 mg/ml) + Manganese chloride tetrahydrate (19.8 μg/ml) + Potassium Iodide (16.6 μg/ml) + Sodium fluoride (0.21 mg/ml) + Sodium molybdate dihydrate (4.85 μg/ml) + Zinc chloride (1.05 mg/ml) Injection, solution, concentrate Intravenous Fresenius Kabi Austria Gmb H 2015-03-02 Not applicable Austria ADDEL JUNIOR Konzentrat zur Herstellung einer Infusionslösung Sodium selenite (4.381 μg/ml) + Copper gluconate (142.8 μg/ml) + Manganese gluconate (4.052 μg/ml) + Potassium Iodide (1.308 μg/ml) + Zinc gluconate (697 μg/ml) Injection, solution, concentrate Intravenous Laboratoire Aguettant 2017-05-17 Not applicable Austria Addnutriv Sodium selenite (79 mcg / 10 mL) + Chromic chloride (10 mcg / 10 mL) + Cupric Chloride (380 mcg / 10 mL) + Ferric chloride (1100 mcg / 10 mL) + Manganese chloride (55 mcg / 10 mL) + Potassium Iodide (130 mcg / 10 mL) + Sodium fluoride (950 mcg / 10 mL) + Sodium molybdate (19 mcg / 10 mL) + Zinc chloride (5000 mcg / 10 mL) Solution Intravenous Fresenius Kabi 2020-12-01 Not applicable Canada Alkadrenergy Tablets Sodium selenite (37.5 mcg) + Ascorbic acid (60 mg) + Beta carotene (2500 unit) + Biotin (150 mcg) + Calcium (50 mg) + Choline (100 mg) + Chromic chloride (5 mcg) + Cyanocobalamin (45 mcg) + Folic acid (0.2 mg) + Inositol (25 mg) + Iodine (0.1 mg) + Magnesium (50 mg) + Manganese (0.5 mg) + Molybdenum (3 mcg) + Nicotinamide (40 mg) + Pantothenic acid (15 mg) + Pyridoxine hydrochloride (6.25 mg) + Riboflavin (6.25 mg) + Thiamine (6.25 mg) + Zinc (9 mg) + alpha-Tocopherol acetate (15 unit) Tablet Oral Morter Healthsystem Not applicable Not applicable Canada Avengers Vitamin and Mineral Supplement Sodium selenite (25 mcg / tab) + Ascorbic acid (25 mg / tab) + Vitamin E (10 unit / tab) + Zinc gluconate (15 mg / tab) Tablet Oral For Mor International Inc. 2000-03-25 2002-06-25 Canada C. Vit-min Formula Sodium selenite (200 mcg) + Ascorbic acid (100 mg) + Biotin (30 mcg) + Calcium (175 mg) + Cholecalciferol (400 unit) + Choline (30 mg) + Chromium (50 mcg) + Copper (5 mg) + Cyanocobalamin (100 mcg) + Ferrous fumarate (10 mg) + Folic acid (0.600 mg) + Inositol (30 mg) + Magnesium (80 mg) + Manganese (5 mg) + Molybdenum (25 mcg) + Nicotinamide (50 mg) + Calcium pantothenate (50 mg) + Potassium (40 mg) + Potassium Iodide (0.15 mg) + Pyridoxine hydrochloride (50 mg) + Racemethionine (3 mg) + Riboflavin (50 mg) + Silicon (0.01 mg) + Thiamine (50 mg) + Vanadium (10 mcg) + Vitamin A (5000 unit) + Zinc (40 mg) + alpha-Tocopherol acetate (100 unit) Tablet Oral Nutramed Laboratories Inc. Not applicable Not applicable Canada Children's Chewable Tab Sodium selenite (2.6 mcg / tab) + Ascorbic acid (33.33 mg / tab) + Beta carotene (333.3 unit / tab) + Biotin (33 mcg / tab) + Chromic chloride (2.2 mcg / tab) + Cyanocobalamin (7.33 mcg / tab) + Folic acid (.1 mg / tab) + Magnesium (23.33 mg / tab) + Manganese sulfate (1.82 mg / tab) + Molybdenum (.7 mcg / tab) + Niacin (.33 mg / tab) + Nicotinamide (2.66 mg / tab) + Calcium pantothenate (5 mg / tab) + Potassium (9.44 mg / tab) + Potassium Iodide (.016 mg / tab) + Pyridoxine hydrochloride (1.66 mg / tab) + Racemethionine (2.66 mg / tab) + Riboflavin (1 mg / tab) + Thiamine mononitrate (1.66 mg / tab) + Vitamin A palmitate (333.3 unit / tab) + Zinc (.95 mg / tab) + alpha-Tocopherol succinate (15 unit / tab) Tablet Oral Nf Formulas Inc. 1988-12-31 2000-06-21 Canada - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Addamel N Sodium selenite (3.2 ug/1mL) + Chromic chloride hexahydrate (1 ug/1mL) + Cuprous chloride (0.13 mg/1mL) + Ferric chloride (0.11 mg/1mL) + Manganese chloride tetrahydrate (0.027 mg/1mL) + Potassium Iodide (0.013 mg/1mL) + Sodium fluoride (0.095 mg/1mL) + Sodium molybdate dihydrate (1.9 ug/1mL) + Zinc chloride (0.65 mg/1mL) Injection, solution Intravenous Fresenius Kabi USA, LLC 2013-05-07 2017-03-31 US ADDAMEL N 20 AMPUL Sodium selenite (69 mcg/10mL) + Chromic chloride (53.3 mcg/10mL) + Cupric Chloride (3.4 mg/10mL) + Ferric chloride (5.4 mg/10mL) + Manganese chloride (990 mcg/10mL) + Potassium Iodide (166 mcg/10mL) + Sodium fluoride (2.1 mg/10mL) + Sodium molybdate (48.5 mcg/10mL) + Zinc chloride (13.6 mg/10mL) Injection, solution Intravenous FRESENİUS KABİ İLAÇ SAN. VE TİC. LTD. ŞTİ. 2020-08-14 Not applicable Turkey ADDAVEN IV INFUZYON ICIN KONSANTRE SOLUSYON Sodium selenite (173 mcg/10mL) + Chromic chloride (53.3 mcg/10mL) + Cupric Chloride (1.02 mg/10mL) + Ferric chloride (5.4 mg/10mL) + Manganese chloride (198 mcg/10mL) + Potassium Iodide (166 mcg/10mL) + Sodium fluoride (2.1 mg/10mL) + Sodium molybdate (48.5 mcg/10mL) + Zinc chloride (10.5 mg/10mL) Injection, solution Intravenous FRESENİUS KABİ İLAÇ SAN. VE TİC. LTD. ŞTİ. 2020-08-14 Not applicable Turkey Multitrace-5 Selenious acid (98 ug/1mL) + Chromic chloride hexahydrate (51.3 ug/1mL) + Cupric sulfate pentahydrate (3.93 mg/1mL) + Manganese sulfate (1.54 mg/1mL) + Zinc sulfate heptahydrate (22 mg/1mL) Injection, solution, concentrate Intravenous AMERICAN REGENT, INC. 1993-09-14 Not applicable US Multitrace-5 Selenious acid (98 ug/1mL) + Chromic chloride hexahydrate (51.3 ug/1mL) + Cupric sulfate pentahydrate (3.93 mg/1mL) + Manganese sulfate (1.54 mg/1mL) + Zinc sulfate heptahydrate (22 mg/1mL) Injection, solution, concentrate Intravenous AMERICAN REGENT, INC. 1993-12-17 Not applicable US Multitrace-5 Selenious acid (32.7 ug/1mL) + Chromic chloride hexahydrate (20.5 ug/1mL) + Cupric sulfate pentahydrate (1.57 mg/1mL) + Manganese sulfate (0.308 mg/1mL) + Zinc sulfate heptahydrate (4.39 mg/1mL) Injection, solution Intravenous AMERICAN REGENT, INC. 1994-02-17 Not applicable US Peditrace Sodium selenite (2 ug/1mL) + Cupric chloride dihydrate (20 ug/1mL) + Manganese chloride tetrahydrate (1 ug/1mL) + Potassium Iodide (1 ug/1mL) + Sodium fluoride (57 ug/1mL) + Zinc chloride (250 ug/1mL) Injection, solution Intravenous Fresenius Kabi USA, LLC 2013-05-09 2016-08-31 US Selenium Selenious acid (65.4 ug/1mL) Injection, solution Intravenous AMERICAN REGENT, INC. 1990-09-30 2021-03-31 US Tricare Prenatal 2-part Daily Prenatal Vitamin System Sodium selenite (.0325 mg/1) + Ascorbic acid (30 mg/1) + Biotin (.150 mg/1) + Cholecalciferol (400 [iU]/1) + Chromium Cr-51 chloride (.060 mg/1) + Copper gluconate (1 mg/1) + Cyanocobalamin (.125 mg/1) + Doconexent (150 1/1) + Ferric pyrophosphate (4.5 mg/1) + Icosapent (37.5 1/1) + Levomefolic acid (1 mg/1) + Manganese citrate decahydrate (1 mg/1) + Nicotinamide (10 mg/1) + Omega-3 fatty acids (75 1/1) + Calcium pantothenate (5 mg/1) + Pyridoxine hydrochloride (2.5 mg/1) + Riboflavin (.85 mg/1) + Sodium molybdate (.0375 mg/1) + Thiamine mononitrate (1.25 mg/1) + Zinc (7 mg/1) + alpha-Tocopherol succinate (15 [iU]/1) Kit Oral Medecor Pharma, Llc 2016-05-10 Not applicable US
Categories
- ATC Codes
- A12CE02 — Sodium selenite
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of inorganic compounds known as non-metal selenites. These are inorganic non-metallic compounds containing a selenite as its largest oxoanion.
- Kingdom
- Inorganic compounds
- Super Class
- Mixed metal/non-metal compounds
- Class
- Other mixed metal/non-metal oxoanionic compounds
- Sub Class
- Non-metal selenites
- Direct Parent
- Non-metal selenites
- Alternative Parents
- Inorganic oxides
- Substituents
- Inorganic oxide / Non-metal selenite
- Molecular Framework
- Not Available
- External Descriptors
- selenium oxoacid (CHEBI:26642) / an anion (SELENITE)
- Affected organisms
- Humans and other mammals
Chemical Identifiers
- UNII
- F6A27P4Q4R
- CAS number
- 7783-00-8
- InChI Key
- MCAHWIHFGHIESP-UHFFFAOYSA-N
- InChI
- InChI=1S/H2O3Se/c1-4(2)3/h(H2,1,2,3)
- IUPAC Name
- selenous acid
- SMILES
- O[Se](O)=O
References
- General References
- Burk RF, Hill KE: Regulation of Selenium Metabolism and Transport. Annu Rev Nutr. 2015;35:109-34. doi: 10.1146/annurev-nutr-071714-034250. Epub 2015 May 13. [Article]
- Tobe T, Ueda K, Aoki A, Okamoto Y, Kojima N, Jinno H: Selenium uptake through cystine transporter mediated by glutathione conjugation. J Toxicol Sci. 2017;42(1):85-91. doi: 10.2131/jts.42.85. [Article]
- Combs GF Jr, Noguchi T, Scott ML: Mechanisms of action of selenium and vitamin E in protection of biological membranes. Fed Proc. 1975 Oct;34(11):2090-5. [Article]
- Zachara BA, Pawluk H, Bloch-Boguslawska E, Sliwka KM, Korenkiewicz J, Skok Z, Ryc K: Tissue level, distribution, and total body selenium content in healthy and diseased humans in Poland. Arch Environ Health. 2001 Sep-Oct;56(5):461-6. doi: 10.1080/00039890109604483. [Article]
- Ganther HE: Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase. Carcinogenesis. 1999 Sep;20(9):1657-66. [Article]
- Zhuang T, Xu H, Hao S, Ren F, Chen X, Pan C, Huang K: Effects of selenium on proliferation, interleukin-2 production and selenoprotein mRNA expression of normal and dexamethasone-treated porcine splenocytes. Res Vet Sci. 2015 Feb;98:59-65. doi: 10.1016/j.rvsc.2014.11.019. Epub 2014 Dec 4. [Article]
- Haratake M, Hongoh M, Ono M, Nakayama M: Thiol-dependent membrane transport of selenium through an integral protein of the red blood cell membrane. Inorg Chem. 2009 Aug 17;48(16):7805-11. doi: 10.1021/ic900988j. [Article]
- Selenious Acid PubChem [Link]
- Selenium (As selenious acid) [Link]
- Selenium overview [Link]
- EPA Label, Selenious Acid [Link]
- High-dose selenium for critically ill patients with systemic inflammation: Pharmacokinetics and pharmacodynamics of selenious acid: A pilot study [Link]
- Selenium, URMC Rochester encyclopedia [Link]
- Absorption, distribution, and retention of inhaled selenious acid and selenium metal aerosols in Beagle dogs [Link]
- Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase [Link]
- Distribution of Selenium in Plasma of French Women: Relation to Age and Selenium Status [Link]
- Interaction between SNPs in selenoprotein P and mitochondrial superoxide dismutase determines prostate cancer risk [Link]
- Selenium in the prevention of atherosclerosis and its underlying mechanisms [Link]
- Selenium Injection [Link]
- Selenious acid as a source of selenium added for nutritional purposes to food supplements [Link]
- Pharmacokinetics and Toxicity of Sodium Selenite in the Treatment of Patients with Carcinoma in a Phase I Clinical Trial: The SECAR Study [Link]
- Application of Sodium Selenite in the Prevention and Treatment of Cancers [Link]
- Selenious Acid Injection [Link]
- Selenium Overview [Link]
- Selenoprotein P [Link]
- FDA Approved Drug Products: Selenious Acid Injection for intravenous administration [Link]
- AIFA Product Information: Selesyn (sodium selenite pentahydrate) oral solution [Link]
- External Links
- Human Metabolome Database
- HMDB0011119
- PubChem Compound
- 1091
- PubChem Substance
- 347827908
- ChemSpider
- 1060
- 36344
- ChEBI
- 26642
- ChEMBL
- CHEMBL2009089
- Wikipedia
- Selenous_acid
- MSDS
- Download (132 KB)
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Completed Treatment Acute Abdomen / Critically Ill Patients / Selenium Deficiency / Sepsis / Trace Element Deficiency 1 4 Completed Treatment Peripartum Cardiomyopathy 1 4 Not Yet Recruiting Treatment Manganese Safety in Adults 1 4 Not Yet Recruiting Treatment Manganese Safety in Pediatric Patients 1 3 Active Not Recruiting Prevention Chemotherapy Induced Peripheral Neuropathy (CIPN) / Fallopian Tube Cancer / Ovarian Cancer / Primary Peritoneal Carcinoma / Recurrent Ovarian Carcinoma 1 3 Active Not Recruiting Treatment Cardiovascular Disease (CVD) 1 3 Completed Treatment Arsenic Exposure / Arsenic Poisoning / Arsenic Toxicity / Arsenical Cancers / Arsenical Keratosis / Arsenical Melanosis / Arsenicosis 1 3 Completed Treatment Left Ventricular Dysfunction 1 3 Completed Treatment Septic Shock / Severe Sepsis 1 2 Completed Treatment Breast Neoplasms / Lymphedema 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection Intravenous 5.33 mcg/ml Injection, solution Intravenous drip Solution Intravenous 5.33 mcg/ml Capsule Oral Tablet Oral Tablet, film coated Tablet Oral 30 mcg / tab Liquid Oral Solution Intravenous Liquid Intravenous Solution Intravenous 40 mcg / mL Injection, solution Intravenous Injection, solution, concentrate Intravenous Solution Intravenous 0.053 mg/10ml Injection, solution, concentrate Intravenous; Parenteral Injection, solution, concentrate Parenteral Solution, concentrate Intravenous Injection Intravenous Tablet Oral Injection, solution, concentrate Intravenous Injection, solution Intravenous 100 Mikrogramm/2ml Solution Oral Injection, solution Intravenous 50 Mikrogramm/ml Injection, solution Intravenous 65.4 ug/1mL Capsule Oral 30 mcg / cap Liquid Intravenous 40 mcg / mL Injection, solution Parenteral Kit Oral Tablet, chewable Oral Powder Oral - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
Property Value Source melting point (°C) 70 MSDS boiling point (°C) 684.9 MSDS water solubility soluble MSDS pKa 2.46 MSDS - Predicted Properties
Property Value Source logP -1.3 Chemaxon pKa (Strongest Acidic) 1.2 Chemaxon Physiological Charge -2 Chemaxon Hydrogen Acceptor Count 4 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 57.53 Å2 Chemaxon Rotatable Bond Count 0 Chemaxon Refractivity 19.69 m3·mol-1 Chemaxon Polarizability 5.84 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available
Enzymes
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- Actions
- Activator
- General Function
- Sh3 domain binding
- Specific Function
- Protects the hemoglobin in erythrocytes from oxidative breakdown.
- Gene Name
- GPX1
- Uniprot ID
- P07203
- Uniprot Name
- Glutathione peroxidase 1
- Molecular Weight
- 22087.94 Da
References
- High-dose selenium for critically ill patients with systemic inflammation: Pharmacokinetics and pharmacodynamics of selenious acid: A pilot study [Link]
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- Actions
- Substrate
- General Function
- Thioredoxin-disulfide reductase activity
- Specific Function
- Isoform 1 may possess glutaredoxin activity as well as thioredoxin reductase activity and induces actin and tubulin polymerization, leading to formation of cell membrane protrusions. Isoform 4 enha...
- Gene Name
- TXNRD1
- Uniprot ID
- Q16881
- Uniprot Name
- Thioredoxin reductase 1, cytoplasmic
- Molecular Weight
- 70905.58 Da
References
- Ganther HE: Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase. Carcinogenesis. 1999 Sep;20(9):1657-66. [Article]
Transporters
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- No
- Actions
- Transporter
- General Function
- Selenium binding
- Specific Function
- Might be responsible for some of the extracellular antioxidant defense properties of selenium or might be involved in the transport of selenium. May supply selenium to tissues such as brain and tes...
- Gene Name
- SEPP1
- Uniprot ID
- P49908
- Uniprot Name
- Selenoprotein P
- Molecular Weight
- 43173.37 Da
References
- Interaction between SNPs in selenoprotein P and mitochondrial superoxide dismutase determines prostate cancer risk [Link]
Drug created at December 03, 2015 16:51 / Updated at December 01, 2023 08:05